Literature DB >> 11713075

Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.

M W Lee-Wing1, M E Ashenhurst.   

Abstract

OBJECTIVE: To determine the prevalence of lacrimal sac pathology in patients undergoing dacryocystorhinostomy (DCR) for primary acquired nasolacrimal duct obstruction (PANDO).
DESIGN: Observational case series. PARTICIPANTS: One hundred sixty-six patients with symptoms of PANDO.
METHODS: A total of 202 lacrimal sac biopsies were obtained from 166 patients undergoing external DCR procedures for symptoms of PANDO. MAIN OUTCOME MEASURES: Patient demographics, presenting symptoms and signs, relevant history, and assessment of the nasolacrimal system were recorded. All lacrimal biopsy specimens were examined histopathologically.
RESULTS: A total of 118 patients (71%) were female and 48 patients (29%) were male. The mean age was 60.7 years (range, 21-93 years). All patients demonstrated epiphora, and 32 patients had dacryocystitis. Duration of symptoms ranged from 6 weeks to 50 years. No lacrimal sac tumors were detected. Sixty-five percent of specimens demonstrated chronic inflammation.
CONCLUSIONS: No neoplasms were detected among 202 lacrimal sac specimens from 166 patients with symptoms of PANDO. Most lacrimal sac specimens demonstrated chronic inflammatory changes. We conclude that a lacrimal sac biopsy should be performed when there is suspicion of a neoplasm based on the clinical, historical, or intraoperative findings, rather than routine biopsy of all patients with PANDO.

Entities:  

Mesh:

Year:  2001        PMID: 11713075     DOI: 10.1016/s0161-6420(01)00783-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  [Selective lacrimal sac biopsy for external dacryocystorhinostomy: a clinical pathological study].

Authors:  L M Heindl; E Treutlein; A G M Jünemann; F E Kruse; L M Holbach
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

2.  Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.

Authors:  Arie Y Nemet; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-22       Impact factor: 3.117

Review 3.  Is routine biopsy of the lacrimal sac wall indicated at dacryocystorhinostomy? A prospective study and literature review.

Authors:  C Merkonidis; C Brewis; M Yung; M Nussbaumer
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 4.  A 7-year prospective study of routine histopathological evaluation of the lacrimal sac wall incisional biopsy specimens obtained during external dacryocystorhinostomy in adults and a review of the literature.

Authors:  Miroslav Knežević; M Stojković; M Jovanović; Z Stanković; Dejan M Rašić
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

Review 5.  [Minimally invasive bypass surgery for nasolacrimal duct obstruction : Transcanalicular laser-assisted dacryocystorhinostomy].

Authors:  K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

Review 6.  Clinical significance of routine lacrimal sac biopsy during dacryocystorhinostomy: A comprehensive review of literature.

Authors:  Zoran Koturović; Miroslav Knežević; Dejan M Rašić
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

7.  Predisposing factors for primary acquired nasolacrimal duct obstruction.

Authors:  Kazuyoshi Ohtomo; Takashi Ueta; Taku Toyama; Miyuki Nagahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-28       Impact factor: 3.117

8.  Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.

Authors:  Sang Min Lee; Helen Lew
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-03       Impact factor: 3.117

9.  Pyogenic granuloma of the lacrimal sac.

Authors:  Bülent Yazici; Ayşe Tör Ayvaz; Sibel Aker
Journal:  Int Ophthalmol       Date:  2007-11-16       Impact factor: 2.031

10.  [Adenocarcinoma in the tear sack after endonasal dacryocystorhinostomy].

Authors:  C S Betz; A Leunig; P Janda; R Jund
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.